key: cord-0328180-0j6q874h
authors: Ogando, Natacha S.; Kazzi, Priscila El; Zevenhoven-Dobbe, Jessika C.; Bontes, Brenda W.; Decombe, Alice; Posthuma, Clara C.; Thiel, Volker; Canard, Bruno; Ferron, François; Decroly, Etienne; Snijder, Eric J.
title: Structure-function analysis of the nsp14 N7-guanine methyltransferase reveals an essential role in Betacoronavirus replication
date: 2021-11-01
journal: bioRxiv
DOI: 10.1101/2021.05.17.444407
sha: 31a56edd5ea2d3a06fe156231d908ccb557bc53d
doc_id: 328180
cord_uid: 0j6q874h

As coronaviruses (CoVs) replicate in the host cell cytoplasm, they rely on their own capping machinery to ensure the efficient translation of their mRNAs, protect them from degradation by cellular 5’ exoribonucleases, and escape innate immune sensing. The CoV nonstructural protein 14 (nsp14) is a bi-functional replicase subunit harboring an N-terminal 3′-to-5′ exoribonuclease (ExoN) domain and a C-terminal (N7-guanine)-methyltransferase (N7-MTase) domain that is presumably involved in viral mRNA capping. Here, we aimed to integrate structural, biochemical, and virological data to assess the importance of conserved N7-MTase residues for nsp14’s enzymatic activities and virus viability. We revisited the crystal structure of severe acute respiratory syndrome (SARS)-CoV nsp14 to perform an in silico comparative analysis between betacoronaviruses. We identified several residues likely involved in the formation of the N7-MTase catalytic pocket, which presents a fold distinct from the Rossmann fold observed in most known MTases. Next, for SARS-CoV and Middle East respiratory syndrome-CoV, site-directed mutagenesis of selected residues was used to assess their importance for in vitro enzymatic activity. Most of the engineered mutations abolished N7-MTase activity, while not affecting nsp14-ExoN activity. Upon reverse engineering of these mutations into different betacoronavirus genomes, we identified two substitutions (R310A and F426A in SARS-CoV nsp14) abrogating virus viability and one mutation (H424A) yielding a crippled phenotype across all viruses tested. Our results identify the N7-MTase as a critical enzyme for betacoronavirus replication and define key residues of its catalytic pocket that can be targeted to design inhibitors with a potential pan-coronaviral activity spectrum. Significance Statement The ongoing SARS-CoV-2 pandemic emphasizes the urgent need to develop efficient broad-spectrum anti-CoV drugs. The structure-function characterization of conserved CoV replicative enzymes is key to identifying the most suitable drug targets. Using a multidisciplinary comparative approach and different betacoronaviruses, we characterized the key conserved residues of the nsp14 (N7-guanine)-methyltransferase, a poorly defined subunit of the CoV mRNA-synthesizing machinery. Our study highlights the unique structural features of this enzyme and establishes its essential role in betacoronavirus replication, while identifying two residues that are critical for the replication of the four betacoronaviruses tested, including SARS-CoV-2.

also supported by the SARS-CoV nsp14 crystal structure (35, 36) which was found to be composed 117 of (i) a flexible N-terminal sub-domain forming the nsp10 binding site (aa 1-58), (ii) the 3'-to-5' which conserved residues may be mechanistically involved in N7-methylation and how important 155 these may be for overall CoV replication. Therefore, we first revisited the core structure of the 156 SARS-CoV N7-MTase, to guide a subsequent biochemical and virological comparison across 157 multiple betacoronaviruses.

In the SARS-CoV nsp14 structure (35), the ExoN core presents a fold characteristic of the domains, one side of the hinge also constitutes the 'ceiling' of the N7-MTase active site (Fig. 1B) .

The structures of SARS-CoV nsp14 in complex with SAM and GpppA (PDB: 5C8S and 174 5C8T; (35)) have defined the enzyme's cap-binding pocket. However, the crystal packing 175 profoundly constrained the structural characterization of the N7-MTase domain and the overall low 176 resolution left uncertainties regarding the positioning of the RNA ligand. Therefore, we performed 177 a thorough structural analysis of the enzyme's cavity, supported by CoV-wide nsp14 sequence 178 comparisons, in order to define conserved N7-MTase residues that may be involved in enzymatic 179 activity (Fig. S2) . Several aspects were taken into consideration while delimiting the SAM and RNA 180 binding sites: the general geometry of the cavity, its electrostatic properties, and the conservation 181 of specific amino acid residues. We used Surfnet software (57) to define the volume corresponding 182 to the ligand-binding cavity (Fig. 1C) . This volume is shaped as a dual bulb, with the larger pocket (Table S3) .

Identification of residues crucial for in vitro N7-MTase activity. To experimentally verify the 209 outcome of our structural analysis ( Fig. 1-2) , we probed the functional importance of selected We evaluated the N7-MTase activity of nsp14 mutants in an assay using a GpppACCCC 

The nsp14 N7-MTase is critical for SARS-CoV viability. As summarized above, most prior 259 biochemical and structural studies of the CoV N7-MTase were performed using SARS-CoV nsp14, 260 whereas mutagenesis in the context of virus replication (using reverse genetics) was restricted to 261 MHV studies in which, for different reasons, the conserved D and G residues in motif III and the Y 262 residue in motif VI were targeted (41, 43, 58). To establish a connection between the biochemical 263 and virological data on the N7-MTase, we first introduced twelve single N7-MTase mutations into 264 the SARS-CoV genome, using a bacterial artificial chromosome-based reverse genetics system. 

Remarkably, SARS-CoV mutations N306A, K336A, and N422A in motifs II, III, and VI, 280 respectively, were found to yield viruses with plaque phenotypes and progeny titers similar to those 281 of the wild-type control (Fig. 5) , despite the major impact of these mutations on in vitro N7-MTase 282 activity (Fig. 3C) . Likewise, the viable but severely crippled (small-plaque) virus phenotypes of 283 motif-I mutant W292A and motif VI-mutant H424A were surprising (Fig. 5B) , although for the latter 284 the biochemical assays did reveal some activity when performed with an increased enzyme 285 concentration ( Fig. 3C and (35) ). Interestingly, mutant D352A yielded a mixed-size plaque 

In general, our data demonstrated the importance of the N7-MTase domain for SARS-CoV 294 viability and confirmed the importance of the motifs and key residues identified using structural 295 biology and biochemical approaches (summary presented in Fig. 5A ). Nevertheless, for several 296 mutants the data from different types of assays did not readily align, which prompted us to expand 297 the reverse genetics efforts to other betacoronaviruses. 

CoV and MHV mutants, using technical procedures similar to those described above for SARS-

CoV (see Methods). In this case, the production of viable progeny was facilitated by co-culturing 

The mutations tested for MERS-CoV and MHV had a large predicted impact in our folding 312 free energy analysis (Table S2 and Table S3 ) and/or yielded a non-viable or crippled phenotype in 313 our SARS-CoV study (Fig. 5A) . We evaluated whether these residues were equally critical for the 314 replication of other betacoronaviruses. For clarity, in the text below we will refer to the conserved 315 key residues of each motif instead of using nsp14 amino acid numbers, which are slightly different 316 when comparing SARS-CoV, MERS-CoV and MHV (see Fig. 5A ).

In contrast to the SARS-CoV result, the replacement of the W in SAM binding site motif I given the fact that this mutation (F422A in MERS-CoV) allowed substantial N7-MTase activity in 332 the in vitro assay (Fig. 3D) . When SARS-CoV-2 emerged during the course of this study, the three 333 mutations that produced a similar phenotype across SARS-CoV, MERS-CoV and MHV (R310A, 334 H424A, and F426A; using SARS-CoV numbering) were also engineered for this newly discovered 335 coronavirus. Again, the R310A and F426A replacements were found to fully abrogate virus 336 replication, while H424A yielded a crippled phenotype in SARS-CoV-2 (Fig. 5) . incorporates twelve β-strands and five α-helices that form a five-stranded β-sheet core (36, 45).

The overall nsp14 structure reveals two domains interconnected by a hinge that may confer the 369 flexibility needed to orchestrate the different functions of the protein during CoV replication (36).

Furthermore, the protein binds to nsp10, a critical co-factor for nsp14's ExoN activity (34, 70). The 

Although the biochemical and virological data presented in this study clearly provide 383 support for the predictions derived from our structural analysis, the overall interpretation of the data 384 set undeniably is much more complex than anticipated (Fig. 5A) . Replacement of conserved SARS-

CoV and MERS-CoV N7-MTase residues largely or completely abrogated enzymatic activity in vitro 386 ( Fig. 3C and 3D) , supporting their identification as key residues for the enzyme's functionality when CoV (crippled) mutants were also variable, adding to the complexity of the overall picture.

A substantial set of N7-MTase mutations was monitored for 'side effects' at the level of in 426 vitro ExoN activity (Fig. 4) , although for SARS-CoV and MHV these would unlikely explain a lack 427 of viability as ExoN knock-out mutants for both these viruses are only mildly crippled (42, 58, 73).

Strikingly, for MERS-CoV, which does not tolerate ExoN inactivation (37), two of the N7-MTase 429 mutations (G333A in motif III and H420A in motif VI) abolished detectable ExoN activity in vitro 430 (Fig. 4B) , but still allowed a certain level of virus replication (small-plaque phenotype), an 431 observation that clearly warrants further investigation. In more general terms, the ExoN biochemical 432 assay (Fig. 4) suggested that the functional separation between the two enzyme domains may be 433 less strict than previously concluded, as also recently hypothesized following an in silico and and ExoN domains (Fig. 1) . For other N7-MTase motifs probed, the functional separation from

ExoN was confirmed, as also deduced from previous studies (27, 33, 35, 38) .

In our reverse genetics studies with four betacoronaviruses, a consistent phenotype was 441 observed only for N7-MTase mutants carrying replacements of the conserved R in motif II (non-442 viable) and the conserved H and F in motif VI (crippled and non-viable, respectively). SARS-CoV 443 residue R310 was previously reported to play a role in SAM binding (33), whereas F426 was 444 proposed to entrench and stabilize the guanosine's purine moiety in the proximity of SAM (35). Our 445 analysis (Fig. 2) redefined both residues as part of putative RNA binding site motifs II and VI, 446 respectively, and they were found to be essential for in vitro N7-MTase activity in SARS-CoV. Our 

Bioinformatics analysis. Forty-seven CoV nsp14 sequences were retrieved (a complete list is 462 provided in Table S1 ) and aligned using MAFFT . Delineation of motif I to VI was done manually 

In vitro nsp14 ExoN assay. Synthetic RNA substrate H4 (34) was radiolabeled at its 5' end using The protein mix was left for 10 min at room temperature to allow the formation of the complex.

Assays were performed at 37°C and stopped by addition of a 3x volume of loading buffer containing 

Data Availability

All study data are included in the article and SI Appendix. Table S2 . * N7-MTase activity of each mutant was 820 compared to the wild-type control enzyme and scored +, +/-, or --when >50%, between 10 and 821 50%, or <10%, respectively. Values used here correspond to results obtained using the high 822 enzyme concentration ( Fig. 3B and 3D ). ** ExoN activity of each mutant was evaluated relative to 823 the wild-type control enzyme and scored +, +/-, or --for equal, reduced, and abolished ExoN 824 activity, respectively. § Mutant virus phenotypes, as deduced from plaque assays, were scored as:

--, non-viable; +/-, severely crippled; ++/-, mildly crippled; ++, similar to the wild-type control. Empty 

Enzymology of RNA cap synthesis

mRNA capping: biological functions and 555 applications

The viral RNA capping machinery as a target 557 for antiviral drugs

Capping of eucaryotic mRNAs

To sense or not to sense viral RNA--essentials of coronavirus innate 560 immune evasion

Conventional and unconventional mechanisms 562 for capping viral mRNA

Viruses know more than one way to don a cap

A pneumonia outbreak associated with a new coronavirus of probable bat 566 origin

The species Severe acute respiratory syndrome-related coronavirus: 568 classifying 2019-nCoV and naming it SARS-CoV-2

Human coronaviruses: what do they cause

Coronaviruses: An Updated Overview of Their 572 Replication and Pathogenesis

Isolation and characterization of a bat SARS-like coronavirus that uses the 574 ACE2 receptor

A SARS-like cluster of circulating bat coronaviruses shows potential 576 for human emergence

Discovery of a rich gene pool of bat SARS-related coronaviruses provides new 578 insights into the origin of SARS coronavirus

Origin and evolution of pathogenic coronaviruses

Unique and conserved features of genome and proteome of SARS-582 coronavirus, an early split-off from the coronavirus group 2 lineage

The Nonstructural Proteins Directing Coronavirus RNA 585 Synthesis and Processing

SARS-coronavirus replication is supported by a reticulovesicular network 587 of modified endoplasmic reticulum

A unifying structural and functional model of the coronavirus replication 589 organelle: Tracking down RNA synthesis

SARS-CoV-2 structure and replication characterized by in situ cryo-electron 591 tomography

The human coronavirus 229E superfamily 1 593 helicase has RNA and DNA duplex-unwinding activities with 5'-to-3' polarity

Human coronavirus 229E nonstructural protein 13: 596 characterization of duplex-unwinding, nucleoside triphosphatase, and RNA 5'-597 triphosphatase activities

Discovery of an essential nucleotidylating activity associated with a 599 newly delineated conserved domain in the RNA polymerase-containing protein of all 600 nidoviruses

Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription 602

Complex Reveals an Intermediate State in Cap Synthesis

Protein-primed RNA synthesis in SARS-CoVs and structural basis for 605 inhibition by AT-527

In vitro reconstitution of SARS-coronavirus mRNA cap methylation

Functional screen reveals SARS coronavirus nonstructural protein nsp14 as 610 a novel cap N7 methyltransferase

Coronavirus nonstructural protein 16 is a cap-0 binding enzyme 612 possessing (nucleoside-2'O)-methyltransferase activity

Biochemical and structural insights into the mechanisms of SARS 614 coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex

Coronaviruses: an 617 RNA proofreading machine regulates replication fidelity and diversity

The curious case of the nidovirus exoribonuclease: its role in RNA 620 synthesis and replication fidelity

Characterization of the guanine-N7 methyltransferase activity of coronavirus 622 nsp14 on nucleotide GTP

Structure-function analysis of severe acute respiratory syndrome 624 coronavirus RNA cap guanine-N7-methyltransferase

RNA 3'-end mismatch excision by the severe acute respiratory syndrome 626 coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex

Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 629 complex

Structural and molecular basis of mismatch correction and ribavirin 631 excision from coronavirus RNA

The enzymatic activity of the nsp14 exoribonuclease is critical for 633 replication of MERS-CoV and SARS-CoV-2

New targets for drug design: importance of nsp14/nsp10 complex 635 formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2

Detecting evolutionary relationships across existing fold space, using 638 sequence order-independent profile-profile alignments

Structural and functional studies of S-641 adenosyl-L-methionine binding proteins: a ligand-centric approach

Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 644 and ORF 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice

High fidelity of murine hepatitis 647 virus replication is decreased in nsp14 exoribonuclease mutants

Mutagenesis of S-adenosyl-l-650 methionine-binding residues in coronavirus nsp14 N7-methyltransferase demonstrates 651 differing requirements for genome translation and resistance to innate immunity

Live attenuated coronavirus vaccines deficient in N7-Methyltransferase 654 activity induce both humoral and cellular immune responses in mice

A N7-guanine RNA cap 657 methyltransferase signature-sequence as a genetic marker of large genome, non-658 mammalian Tobaniviridae

Discovery of the first insect nidovirus, a missing evolutionary link in the 660 emergence of the largest RNA virus genomes

A planarian 662 nidovirus expands the limits of RNA genome size

Yeast-based assays for the high-throughput screening of inhibitors of 664 coronavirus RNA cap guanine-N7-methyltransferase

Toward the identification of viral cap-methyltransferase inhibitors by 666 fluorescence screening assay

Synthesis of adenine dinucleosides SAM analogs as specific 668 inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase

Potent and selective inhibition of SARS coronavirus replication by 671 aurintricarboxylic acid

The 3'-5' exonuclease site of DNA 673 polymerase III from gram-positive bacteria: definition of a novel motif structure

Exoribonuclease superfamilies: structural analysis and 676 phylogenetic distribution

RNA methyltransferases involved in 678 5' cap biosynthesis

Rossmann-Fold Methyltransferases: 680 Taking a "beta-Turn" around Their Cofactor, S-Adenosylmethionine

Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease 683

SURFNET: a program for visualizing molecular surfaces, cavities, and 685 intermolecular interactions

Effects of mutagenesis of 687 murine hepatitis virus nsp1 and nsp14 on replication in culture

Functional and evolutionary analysis of viral 690 proteins containing a Rossmann-like fold

Comparison of super-secondary structures in proteins

Bluetongue virus VP4 is an RNA-capping 694 assembly line

RNA synthesis in a cage--structural 696 studies of reovirus polymerase lambda3

An RNA cap (nucleoside-2'-698 O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and 699 functional characterization

Comparative analysis of RNA genomes of mouse hepatitis 701 viruses

Discontinuous and non-discontinuous 703 subgenomic RNA transcription in a nidovirus

A complex zinc finger controls the enzymatic activities of nidovirus 705 helicases

Development of a High-Throughput Screening Assay to Identify 707 Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass 708

Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM 710

Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule 713 inhibitors of Nsp14 RNA cap methyltransferase

Coronavirus Nsp10, a critical co-factor for activation of multiple 715 replicative enzymes

Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-717 2 polymerase reveals mechanisms for capping and proofreading

Structural basis of mismatch recognition by a SARS-CoV-2 proofreading 720 enzyme

Coronaviruses lacking 722 exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading 723 and potential therapeutics

SeaView version 4: A multiplatform graphical user 725 interface for sequence alignment and phylogenetic tree building

WebLogo: a sequence logo generator

UCSF Chimera--a visualization system for exploratory research and 730 analysis

Improvements to the APBS biomolecular solvation software suite

PoPMuSiC 2.1: a web server for the 734 estimation of protein stability changes upon mutation and sequence optimality

Better prediction of functional effects for sequence 737 variants

Coronavirus nsp10/nsp16 methyltransferase can be targeted by nsp10-739 derived peptide in vitro and in vivo to reduce replication and pathogenesis

Arterivirus Nsp1 modulates the 742 accumulation of minus-strand templates to control the relative abundance of viral 743 mRNAs

MERS-coronavirus replication induces severe in vitro cytopathology 745 and is strongly inhibited by cyclosporin A or interferon-alpha treatment

En passant mutagenesis: a two step markerless 748 red recombination system

Engineering a replication-competent, propagation-defective Middle 750 East respiratory syndrome coronavirus as a vaccine candidate

Middle East respiratory coronavirus accessory protein 4a inhibits PKR-753 mediated antiviral stress responses

Reverse genetic characterization of the natural genomic deletion in 755 SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating 756 function of the 7b protein in-vitro and in-vivo

The nsp3 macrodomain promotes virulence in mice with coronavirus-758 induced encephalitis

Rapid reconstruction of SARS-CoV-2 using a synthetic genomics 760 platform

Reverse genetics of SARS-related coronavirus using vaccinia 762 virus-based recombination

Double-stranded RNA 764 is produced by positive-strand RNA viruses and DNA viruses but not in detectable 765 amounts by negative-strand RNA viruses

SARS-coronavirus replication/transcription complexes are 767 membrane-protected and need a host factor for activity in vitro

Figure 1. Global architecture of coronavirus nsp14. (A) Architecture of SARS-CoV nsp14

N-terminal ExoN domain (yellow), hinge subdomain 775 (blue), and C-terminal N7-MTase domain (brown). (B) Side and top view of the hinge region and 776 N7-MTase domain. The three strands of the hinge (blue) protrude from the N7-MTase domain 777 (brown). (C) Analysis of the volume of the N7-MTase active site, with the cavity highlighted in green 778 and hinge subdomain in blue. (D) Electrostatic surface representation of the CoV nsp14 hinge 779 region and N7-MTase domain

CoV 784 nsp14 amino acid sequence conservation plotted on the structure (PDB 5NFY) of the SARS-CoV 785 hinge region and N7-MTase domain (dark blue to white shading representing 100% to less than 786 50% sequence identity). A list of sequences used for this comparison is

Close-up of identified conserved motifs and residues in the N7-MTase catalytic pocket

WebLogo representation of 6 conserved motifs (I-VI) identified in the N7-MTase catalytic pocket

Each motif is highlighted with a specific color (matching that in panel B) and categorized as a 790 proposed SAM-or RNA-binding motif. Black stars highlight charged or aromatic residues most 791 likely involved in ligand binding or catalytic activity

Expression and in vitro N7-MTase activity of SARS-CoV and MERS-CoV nsp14 796 mutants. Recombinant SARS-CoV (A) and MERS-CoV (B) wild-type and mutant nsp14 proteins 797 were expressed in E. coli and purified

respectively) and analyzed using 10% SDS-PAGE gels stained with Coomassie blue

MERS-CoV (D) nsp14 mutants was 800 determined using an assay with a GpppACCCC synthetic RNA substrate and radiolabeled SAM as 801 methyl donor. Nsp14 concentrations of 50 and 200 nM were used, as indicated. N7-MTase 802 activities were compared to those of the respective wild-type nsp14 controls. For MERS-CoV